Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bliv vs Medivive

Bliv
Graded #187

Higher grade

vs+6.599999999999994
Medivive
Graded #335

Lower grade

The verdict

Bliv takes it — 66.3/100 to 59.7/100.

Bliv grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bliv is a telehealth provider selling personalised compounded GLP-1 programmes.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
71
71
Dose & formulationBliv +24
64
40
Clinical oversightBliv +19
82
63
Labs & monitoringMedivive +11
53
64
FulfillmentBliv +4
65
61
Contract termsMedivive +10
45
55
Bliv · left barMedivive · right bar

The numbers

MetricBlivMedivive
WeighScore66.3/10059.7/100
GradeCC
Scorecard rank#187#335
Semaglutide$116/mo (as low as, varies by plan and eligibility, compounded)Not disclosed
Tirzepatide$199/mo (as low as, varies by plan and eligibility, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Bliv

Graded #187 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • The advertised rates are 'as low as' figures footnoted 'based on plan structure and eligibility', and the plan selector sits behind the medical intake — the rate you are offered is not knowable before you hand over a medical history
  • A $24.99 provider consultation fee is charged on top, and the refund policy deducts $200 for 'clinical coordination and account setup'
  • The homepage advertises 'no long-term commitments or cancellation fees' while the terms require the membership fee to be paid 'in a single sum', call it non-refundable and refer to a 'Membership Term'
  • The only figure smaller than the advertised rate is a $29 CareCredit/Klarna instalment, which is a financing payment rather than the price of a month of medication
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Medivive

Graded #335 · C

Strengths

  • Compounded semaglutide and tirzepatide with providers licensed in all 50 states
  • No insurance required; one-stop for GLP-1 plus TRT, NAD+ and longevity care
  • Medication filled through a licensed pharmacy

Where it loses points

  • Monthly pricing not published; disclosed only after an AI intake
  • No legal entity or named pharmacy disclosed
  • Service states are not individually listed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard